Clinical trial
A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine…
NCT00344305 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00344305 |
|---|---|
| Title | A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children |
| Official title | A Phase 2, Open-Label, Single Arm Trial to Evaluate the Shedding and Safety of CAIV-T Administered to Children 6 to Less Than 60 Months of Age |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | Trivalent influenza virus vaccine live, intranasal |
| Enrollment | 200 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jun 26, 2006 |
| Last update posted | Jul 24, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: